Innate Immune Invisible Ultrasmall Gold Nanoparticles-Framework for Synthesis and Evaluation.
Ontology highlight
ABSTRACT: Nanomedicine is seen as a potential central player in the delivery of personalized medicine. Biocompatibility issues of nanoparticles have largely been resolved over the past decade. Despite their tremendous progress, less than 1% of applied nanosystems can hit their intended target location, such as a solid tumor, and this remains an obstacle to their full ability and potential with a high translational value. Therefore, achieving immune-tolerable, blood-compatible, and biofriendly nanoparticles remains an unmet need. The translational success of nanoformulations from bench to bedside involves a thorough assessment of their design, compatibility beyond cytotoxicity such as immune toxicity, blood compatibility, and immune-mediated destruction/rejection/clearance profile. Here, we report a
SUBMITTER: Zhu GH
PROVIDER: S-EPMC8289183 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
ACCESS DATA